MX2012002385A - Inhibidores macrociclicos de cinasa janus. - Google Patents
Inhibidores macrociclicos de cinasa janus.Info
- Publication number
- MX2012002385A MX2012002385A MX2012002385A MX2012002385A MX2012002385A MX 2012002385 A MX2012002385 A MX 2012002385A MX 2012002385 A MX2012002385 A MX 2012002385A MX 2012002385 A MX2012002385 A MX 2012002385A MX 2012002385 A MX2012002385 A MX 2012002385A
- Authority
- MX
- Mexico
- Prior art keywords
- jak
- macrocyclic inhibitors
- macrocyclic
- inhibitors
- immune
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
Abstract
La presente invención se relaciona con el uso de compuestos macrocíclicos nuevos de la fórmula (I), en donde las variables Q, Q1, Q2, Q3, y Q4 son definidas como se describió aquí, las cuales inhiben JAK y son útiles para el tratamiento de enfermedades autoinmunes e inflamatorias.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24421609P | 2009-09-21 | 2009-09-21 | |
US37296910P | 2010-08-12 | 2010-08-12 | |
PCT/EP2010/063682 WO2011033053A1 (en) | 2009-09-21 | 2010-09-17 | Macrocyclic inhibitors of jak |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2012002385A true MX2012002385A (es) | 2012-04-02 |
Family
ID=43034482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012002385A MX2012002385A (es) | 2009-09-21 | 2010-09-17 | Inhibidores macrociclicos de cinasa janus. |
Country Status (11)
Country | Link |
---|---|
US (1) | US8318764B2 (es) |
EP (1) | EP2480554B1 (es) |
JP (1) | JP5540100B2 (es) |
KR (1) | KR101438293B1 (es) |
CN (1) | CN102498113B (es) |
BR (1) | BR112012006176A2 (es) |
CA (1) | CA2771176A1 (es) |
ES (1) | ES2509590T3 (es) |
MX (1) | MX2012002385A (es) |
RU (1) | RU2012116003A (es) |
WO (1) | WO2011033053A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104023728B (zh) * | 2011-09-30 | 2016-11-02 | 益普生制药股份有限公司 | 大环lrrk2激酶抑制剂 |
CN102617599B (zh) * | 2012-04-10 | 2014-04-16 | 江苏先声药物研究有限公司 | 大环类化合物及其应用 |
US9165142B1 (en) * | 2013-01-30 | 2015-10-20 | Palo Alto Networks, Inc. | Malware family identification using profile signatures |
WO2018153546A1 (en) * | 2017-02-27 | 2018-08-30 | Laboratorios Del Dr. Esteve, S.A. | Tetrahydropyran and tetrahydrothiopyran methanone derivatives having multimodal activity against pain |
US10764309B2 (en) | 2018-01-31 | 2020-09-01 | Palo Alto Networks, Inc. | Context profiling for malware detection |
US11159538B2 (en) | 2018-01-31 | 2021-10-26 | Palo Alto Networks, Inc. | Context for malware forensics and detection |
WO2020092015A1 (en) | 2018-11-02 | 2020-05-07 | University Of Rochester | Therapeutic mitigation of epithelial infection |
CN113735856A (zh) * | 2020-05-29 | 2021-12-03 | 百极弘烨(南通)医药科技有限公司 | 大环jak抑制剂及其应用 |
US11956212B2 (en) | 2021-03-31 | 2024-04-09 | Palo Alto Networks, Inc. | IoT device application workload capture |
WO2023208244A1 (zh) * | 2022-04-29 | 2023-11-02 | 南京明德新药研发有限公司 | 大环类化合物及其应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6235740B1 (en) * | 1997-08-25 | 2001-05-22 | Bristol-Myers Squibb Co. | Imidazoquinoxaline protein tyrosine kinase inhibitors |
AU756838B2 (en) | 1998-03-04 | 2003-01-23 | Bristol-Myers Squibb Company | Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
WO2005030776A1 (en) | 2003-09-23 | 2005-04-07 | Vertex Pharmaceuticals Incorporated | Pyrazolopyrrole derivatives as protein kinase inhibitors |
AU2007315234A1 (en) * | 2006-10-30 | 2008-05-08 | Novartis Ag | Heterocyclic compounds as antiinflammatory agents |
CN101568540A (zh) * | 2006-11-01 | 2009-10-28 | 沃泰克斯药物股份有限公司 | 用作janus激酶抑制剂的三环杂芳基化合物 |
WO2008060248A1 (en) * | 2006-11-15 | 2008-05-22 | S*Bio Pte Ltd. | Indole sustituted pyrimidines and use thereof in the treatment of cancer |
ES2415863T3 (es) | 2006-12-22 | 2013-07-29 | Incyte Corporation | Heterociclos sustituidos como inhibidores de Janus Quinasas |
PE20110223A1 (es) | 2008-06-10 | 2011-05-07 | Abbvie Inc | DERIVADOS DE PIRROLO[2,3-e][1,2,4]TRIAZOLO[4,3-a]PIRAZIN, COMO INHIBIDORES DE QUINASA |
-
2010
- 2010-09-17 CA CA2771176A patent/CA2771176A1/en not_active Abandoned
- 2010-09-17 CN CN201080041995.6A patent/CN102498113B/zh not_active Expired - Fee Related
- 2010-09-17 KR KR1020127010263A patent/KR101438293B1/ko not_active IP Right Cessation
- 2010-09-17 RU RU2012116003/04A patent/RU2012116003A/ru not_active Application Discontinuation
- 2010-09-17 BR BR112012006176A patent/BR112012006176A2/pt not_active IP Right Cessation
- 2010-09-17 JP JP2012529280A patent/JP5540100B2/ja not_active Expired - Fee Related
- 2010-09-17 MX MX2012002385A patent/MX2012002385A/es active IP Right Grant
- 2010-09-17 ES ES10755150.9T patent/ES2509590T3/es active Active
- 2010-09-17 US US12/884,243 patent/US8318764B2/en not_active Expired - Fee Related
- 2010-09-17 WO PCT/EP2010/063682 patent/WO2011033053A1/en active Application Filing
- 2010-09-17 EP EP10755150.9A patent/EP2480554B1/en not_active Not-in-force
Also Published As
Publication number | Publication date |
---|---|
KR20120068940A (ko) | 2012-06-27 |
KR101438293B1 (ko) | 2014-09-05 |
ES2509590T3 (es) | 2014-10-17 |
EP2480554B1 (en) | 2014-08-06 |
US8318764B2 (en) | 2012-11-27 |
JP5540100B2 (ja) | 2014-07-02 |
CN102498113A (zh) | 2012-06-13 |
WO2011033053A1 (en) | 2011-03-24 |
EP2480554A1 (en) | 2012-08-01 |
BR112012006176A2 (pt) | 2015-09-08 |
CA2771176A1 (en) | 2011-03-24 |
RU2012116003A (ru) | 2013-10-27 |
CN102498113B (zh) | 2014-11-26 |
US20110071179A1 (en) | 2011-03-24 |
JP2013505219A (ja) | 2013-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010008198A (es) | Inhibidores de cinasa de pirrolopirazina. | |
PL2250172T3 (pl) | Pirolopirazynowe inhibitory kinazy | |
TW200942543A (en) | Pyrrolopyrazine kinase inhibitors | |
MX2012002385A (es) | Inhibidores macrociclicos de cinasa janus. | |
MX2014002442A (es) | Inhibidores de pirrolopirazina cinasa. | |
ATE517107T1 (de) | Pyrrolopyrazinkinaseinhibitoren | |
MX2012002641A (es) | Inhibidores de cinasa janus (jak). | |
WO2011117145A3 (en) | Pyrrolopyrazine kinase inhibitors | |
ATE522534T1 (de) | Pyrrolopyrazin-kinasehemmer | |
MX343561B (es) | Compuestos de imidazolpiridazina. | |
PT2470546E (pt) | Compostos de hexa-hidrooxazinopteridina para serem utilizados como inibidores de mtor | |
MX342310B (es) | Compuestos de tiazolopirimidina. | |
MX352928B (es) | Compuestos de piridazina-amida. | |
UA108743C2 (uk) | Похідні хіназолін-4(3н)-ону для застосування як інгібіторів рі3-кінази | |
MX2012008874A (es) | Macrociclos como inhibidores del factor de coagulacion (fxia). | |
MY160468A (en) | Novel amino azaheterocyclic carboxamides | |
MA32551B1 (fr) | Nouveaux composes utiles pour le traitement de maladies degeneratives et inflammatoires | |
GEP20135964B (en) | Inhibitors of beta-secretase | |
IN2012DN00869A (es) | ||
MX353257B (es) | Compuestos heterociclicos utiles como inhibidores de proteina cinasa-1 dependiente de 3-fosfoinositido (pdk1). | |
MX2012001419A (es) | Compuestos biciclicos novedosos de urea. | |
MX2011011272A (es) | Procesos e intermediarios. | |
MX2012001413A (es) | Compuestos azaheterociclicos novedosos. | |
MX349548B (es) | Compuestos de tienopirimidina. | |
MX2012007341A (es) | Inhibidores de proteasoma y procesos para su preparacion, purificacion y uso. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |